Factors associated with treatment outcome of multidrug-resistant tuberculosis patients co-infected with human immunodeficiency virus in a Drug Resistant Tuberculosis Centre

Chikkahonnaiah P, Surendran A, Anaswara KS, Kamble N

Pdf Page Numbers :- 71-75

Prashanth Chikkahonnaiah^1,*, Amrudha Surendran¹, Anaswara KS¹, and Nandini Kamble²

¹Department of Respiratory Medicine, Mysore Medical College and Research Institute, Mysuru, Karnataka-570001, India

²Princess Krishnarajamani Tuberculosis and Chest DiseasesHospital, Kumbarakoppal, Mysuru, Karnataka-570002, India

*Corresponding author: Dr. Prashanth Chikkahonnaiah, Head of the Department, Department of Respiratory Medicine, Mysore Medical College and Research Institute, Mysuru-570001, Karnataka, India. Email: prshnthcr@gmail.com

Received 10 February 2022; Revised 14 March 2022; Accepted 22 March 2022; Published 29 March 2022

Citation: Chikkahonnaiah P, Surendran A, Anaswara KS, Kamble N. Factors associated with treatment outcome of multidrug-resistant tuberculosis patients co-infected with human immunodeficiency virus in a Drug Resistant Tuberculosis Centre. J Med Sci Res. 2022; 10(2):71-75. DOI: http://dx.doi.org/10.17727/JMSR.2022/10-14

Copyright: © 2022 Chikkahonnaiah P et al. Published by KIMS Foundation and Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PDF

Abstract

Background: Tuberculosis is one of the major public health problem, further complicated by the relentless spread of human immunodeficiency virus (HIV). The incidence of drug resistant TB among HIV patients is now increasing. Treatment outcomes in multidrug-resistant tuberculosis (MDR-TB) patients co-infected with HIV is poorly documented.

Objectives: Assessed the treatment outcome of MDR-TB co-infected with HIV treated under programmatic management of drug resistant tuberculosis.

Methods: The study was conducted in Department of Respiratory Medicine, Princess Krishnajammanni Tuberculosis and Chest Diseases (PK TB & CD) Hospital, Mysore Medical College and Research Institute (MMCRI), Mysore. It is a retrospective study done on patients who were admitted in DRTB center of PK TB & CD hospital, Mysore for initiation of treatment from January 2013 to December 2019.

Results: Among the 63 patients studied, 26 patients (41.3%) had a favorable outcome with cure and treatment completed. 25 patients (39.7%) had an unfavorable outcome with death, 9 patients (14.3%) defaulted during the treatment and 2 patients (3.2%) had failure of therapy.

Conclusion: Early recognition and treatment of HIV with ART and the clinical stage of the disease during presentation affect the treatment outcome in patients with MDR-TB.

Keywords: tuberculosis; HIV; outcome; multidrug resistance; ART